ArticleEuropean journal of cancer care2019

Treatment patterns and outcomes in patients with non-small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropaenia: Results from the MONITOR-GCSF study.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.